Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
3CLpro
Description:
A viral main protease that cleaves polyproteins and is studied as a target and functional enzyme in coronavirus research.
Primary topic:
Computational Drug Discovery Methods (41%)
Related topics:
Computational Drug Discovery Methods (41%),
SARS-CoV-2 and COVID-19 Research (32%)
OpenAlex ID:
keywords/3clpro
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
2003
·
Kanchan Anand
, John Ziebuhr
, et al.
·
Science
·
1,879
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
2020
·
Muhammad Tahir ul Qamar
, Safar M. Alqahtani
, et al.
·
Journal of Pharmaceutical Analysis
·
1,087
PDF
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
2020
·
Lifeng Fu
, Fei Ye
, et al.
·
Nature Communications
·
569
PDF
Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme
2006
·
Kiira Ratia
, Kumar Singh Saikatendu
, et al.
·
Proceedings of the National Academy of Sciences
·
437
PDF
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
2020
·
Salman Ali Khan
, Komal Zia
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
370
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
2020
·
Bhupesh Goyal
, Deepti Goyal
·
ACS Combinatorial Science
·
368
PDF
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study
2020
·
Priya Shree
, Priyanka Mishra
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
348
Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors
2017
·
Ji-Young Park
, Heung Joo Yuk
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
325
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
2020
·
Olga Abian
, David Ortega-Alarcon
, et al.
·
International Journal of Biological Macromolecules
·
281
PDF
In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
2020
·
Seshu Vardhan
, Suban K. Sahoo
·
Computers in Biology and Medicine
·
272
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
2004
·
Jan E. Blanchard
, Nadine H. Elowe
, et al.
·
Chemistry & Biology
·
215
PDF
Natural products for COVID ‐19 prevention and treatment regarding to previous coronavirus infections and novel studies
2020
·
Motahareh Boozari
, Hossein Hosseinzadeh
·
Phytotherapy Research
·
209
Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling
2020
·
Marina Macchiagodena
, Marco Pagliai
, et al.
·
Chemical Physics Letters
·
202
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir
2023
·
Dirk Jochmans
, Cheng Liu
, et al.
·
mBio
·
201
PDF
In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach
2020
·
Papia Chowdhury
·
Journal of Biomolecular Structure and Dynamics
·
198
Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
2007
·
Valerie Grum-Tokars
, Kiira Ratia
, et al.
·
Virus Research
·
198
PDF
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro)
2015
·
Sakshi Tomar
, Melanie L. Johnston
, et al.
·
Journal of Biological Chemistry
·
178
PDF
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies
2020
·
Sumit Kumar
, Prem Prakash Sharma
, et al.
·
Journal of Chemical Information and Modeling
·
166
PDF
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
2020
·
Seri Jo
, Suwon Kim
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
163
Quaternary Structure of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Main Protease
2004
·
Chi-Yuan Chou
, Hui-Chuan Chang
, et al.
·
Biochemistry
·
156
AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2
2022
·
Bowen Tang
, Fengming He
, et al.
·
Biomolecules
·
155
PDF
Flavonoids against the SARS-CoV-2 induced inflammatory storm
2021
·
Alena Liskova
, Marek Samec
, et al.
·
Biomedicine & Pharmacotherapy
·
155
PDF
A planarian nidovirus expands the limits of RNA genome size
2018
·
Amir Saberi
, Anastasia A. Gulyaeva
, et al.
·
PLoS Pathogens
·
151
PDF
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
2020
·
Rajaiah Alexpandi
, Joelma Freire De Mesquita
, et al.
·
Frontiers in Microbiology
·
149
PDF
The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
2022
·
Ryan P. Joyce
, Vivian W. Hu
, et al.
·
Medicinal Chemistry Research
·
139
PDF
Show more works
View as search
Works count:
1,031
Citation count:
23,590
Year
Topic
Type